Management of congenital ichthyoses: European guidelines of care, part two.


Journal

The British journal of dermatology
ISSN: 1365-2133
Titre abrégé: Br J Dermatol
Pays: England
ID NLM: 0004041

Informations de publication

Date de publication:
03 2019
Historique:
accepted: 04 06 2018
pubmed: 14 6 2018
medline: 25 2 2020
entrez: 14 6 2018
Statut: ppublish

Résumé

These guidelines for the management of congenital ichthyoses have been developed by a multidisciplinary group of European experts following a systematic review of the current literature, an expert conference held in Toulouse in 2016, and a consensus on the discussions. These guidelines summarize evidence and expert-based recommendations and intend to help clinicians with the management of these rare and often complex diseases. These guidelines comprise two sections. This is part two, covering the management of complications and the particularities of some forms of congenital ichthyosis.

Identifiants

pubmed: 29897631
doi: 10.1111/bjd.16882
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

484-495

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2018 British Association of Dermatologists.

Auteurs

J Mazereeuw-Hautier (J)

Reference Centre for Rare Skin Diseases, Dermatology Department, Larrey Hospital, Toulouse, France.

A Hernández-Martín (A)

Department of Dermatology, Hospital Infantil Niño Jesús, Madrid, Spain.

E A O'Toole (EA)

Centre for Cell Biology and Cutaneous Research, Blizard Institute, Barts, and the London School of Medicine and Dentistry, Queen Mary University of London, London, U.K.

A Bygum (A)

Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark.

C Amaro (C)

Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal.

M Aldwin (M)

Ichthyosis Support Group, PO Box 1242, Yateley, GU47 7FL, U.K.

A Audouze (A)

Association Ichtyose France, Bellerive sur Allier, France.

C Bodemer (C)

Department of Dermatology, Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Hôpital Saint-Louis, Paris, France.
Institut Imagine, Université Descartes, Sorbonne Paris Cité, Hôpital Necker-Enfants Malades, Paris, France.

E Bourrat (E)

Department of Dermatology, Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Hôpital Saint-Louis, Paris, France.

A Diociaiuti (A)

Dermatology Division, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.

M Dolenc-Voljč (M)

Department of Dermatovenereology, University Medical Centre Ljubljana, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

I Dreyfus (I)

Reference Centre for Rare Skin Diseases, Dermatology Department, Larrey Hospital, Toulouse, France.

M El Hachem (M)

Dermatology Division, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.

J Fischer (J)

Institute of Human Genetics, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

A Ganemo (A)

Department of Dermatology, Institute of Clinical Research in Malmö, Skåne University Hospital, Lund University, Malmö, Sweden.

C Gouveia (C)

Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

R Gruber (R)

Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.

S Hadj-Rabia (S)

Department of Dermatology, Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Hôpital Saint-Louis, Paris, France.
Institut Imagine, Université Descartes, Sorbonne Paris Cité, Hôpital Necker-Enfants Malades, Paris, France.

D Hohl (D)

Department of Dermatology, Hôpital de Beaumont, Lausanne, Switzerland.

N Jonca (N)

Epithelial Differentiation and Rheumatoid Autoimmunity Unit (UDEAR), UMR 1056 Inserm - Toulouse 3 University, Purpan Hospital, Toulouse, France.

K Ezzedine (K)

Depatment of Dermatology, Hôpital Henri Mondor, EA EpiDerm, UPEC-Université Paris-Est Créteil, 94010, Créteil, France.

D Maier (D)

Dermatology Department, Iuliu Haţieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

R Malhotra (R)

Corneoplastic Unit, Queen Victoria Hospital NHS Trust, East Grinstead, West Sussex, U.K.

M Rodriguez (M)

Department of Ear, Nose and Throat, Hospital Universitario Son Espases, Palma de Mallorca, Spain.

H Ott (H)

Division of Pediatric Dermatology and Allergology, Auf Der Bult Children's Hospital, Hanover, Germany.

D G Paige (DG)

Department of Dermatology, Royal London Hospital, Barts Health NHS Trust, London, E1 1BB, U.K.

A Pietrzak (A)

Department of Dermatology, Venereology and Paediatric Dermatology, Medical University of Lublin, Lublin, Poland.

F Poot (F)

ULB-Erasme Hospital, Department of Dermatology, Brussels, Belgium.

M Schmuth (M)

Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.

J C Sitek (JC)

Department of Dermatology and Centre for Rare Disorders, Oslo University Hospital, Oslo, Norway.

P Steijlen (P)

Department of Dermatology, Maastricht University Medical Centre, GROW Research School for Oncology and Developmental Biology, Maastricht, the Netherlands.

G Wehr (G)

Selbsthilfe Ichthyose, Kürten, Germany.

M Moreen (M)

Department of Dermatology, University Hospitals Leuven, Leuven, Belgium.
Department of Microbiology and Immunology KU Leuven, Leuven, Belgium.

A Vahlquist (A)

Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

H Traupe (H)

Department of Dermatology, University Hospital of Münster, Von-Esmarch-Straße 58, D-48149, Münster, Germany.

V Oji (V)

Department of Dermatology, University Hospital of Münster, Von-Esmarch-Straße 58, D-48149, Münster, Germany.
Hautarztpraxis am Buddenturm, Rudolf-von-Langen-Straße 55, D-48147, Münster, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH